Fig. 6From: Network pharmacology and experimental validation methods to reveal the active compounds and hub targets of Curculigo orchioides Gaertn in rheumatoid arthritisRepresentative images of molecular docking. a–c Curculigoside with MMP9, JUN, and PTGS2, respectively. d–f Orcinol glucoside with MMP9, JUN, and PTGS2, respectivelyBack to article page